End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.58 USD | -3.00% | +0.59% | +18.29% |
May. 24 | Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating | MT |
May. 22 | Alvotech Narrows Q1 Loss as Revenue Increases; Shares Head Higher Premarket | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.29% | 3.97B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals